Brecon Pharmaceuticals and Anderson Packaging Realign Businesses to Form Full Service Global Pharmaceutical Packaging Company, AndersonBrecon

AndersonBrecon to offer more integrated, seamless approach for the global launch of pharmaceutical products.

Powys, UK (June 6, 2012) - Brecon Pharmaceuticals, a leading supplier of pharmaceutical commercial packaging solutions in the UK, and Anderson Packaging, one of the fastest growing pharmaceutical clinical and commercial contract packagers in the United States, today announced they are further aligning their businesses to become a global end-to-end pharmaceutical packaging company. Both part of the AmerisourceBergen Corporation, the companies will provide innovative and differentiated packaging solutions under the name AndersonBrecon.

AndersonBrecon will feature 12 facilities across two continents, and more than 1,500 dedicated associates who will work to provide lifesaving medications to patients in more than 100 countries around the world. Though Brecon Pharmaceuticals and Anderson Packaging have been working together since 2006, the repositioning will enable both to better respond to the evolving pharmaceutical marketplace and provide efficient and more competitive solutions to meet customers’ global needs.

“Over the last four years, the Brecon and Anderson teams have worked together to build the foundation for a truly global healthcare packaging partner, and have demonstrated we understand our customers and can provide comprehensive, seamless solutions,” said Peyton Howell, President of AmerisourceBergen Consulting Services. “Moving to a more global organisation will better position us to offer our customers a more integrated approach for the global launch of pharmaceutical products, helping to accelerate speed-to-market and product success – and achieve an unparalleled level of customer service in the industry.”

Peter Belden, Managing Director of AndersonBrecon UK comments: “We are delighted to announce that we are realigning Brecon Pharmaceuticals and Anderson Packaging to become a single, full-service pharmaceutical packaging company. These new developments mean that we can offer our customers in Europe and beyond true global reach, with enhanced capacity and global service capabilities that enable us to support every stage of the product lifecycle, from research and development through to commercialisation and long-term supply.”

As part of the repositioning effort, AndersonBrecon has become a component of AmerisourceBergen Consulting Services (ABCS), a business unit of AmerisourceBergen that is comprised of market leading consulting companies including Xcenda, Lash Group, TheraCom and Premier Source. ABCS partners with manufacturers to prove product value and expand market access. The organisation offers unparalleled commercialisation support by integrating outcomes research, health policy analysis, managed markets agency services, reimbursement strategy, contract field staffing – and now, packaging and clinical services through AndersonBrecon.

For more information on AndersonBrecon and its services, please visit www.andersonbrecon.com or follow them on Twitter at www.twitter.com/andersonbrecon.

About AndersonBreconAndersonBrecon, a business unit of AmerisourceBergen Consulting Services, a subsidiary of AmerisourceBergen Corporation, is a leading provider of contract packaging services to the global healthcare market. With facilities in North America and Europe, AndersonBrecon supports pharmaceutical and biotech companies with products destined for more than 100 countries around the world. AndersonBrecon provides services for each stage of the product lifecycle – from early Phase I through commercial launch and long-term supply – and partners with customers to provide key insight and expertise in enabling successful commercialization and bringing lifesaving medications to patients. For more information, go to www.andersonbrecon.com.

About AmerisourceBergenAmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from niche premium logistics and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With more than $80 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 13,000 people. AmerisourceBergen is ranked #29 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.

Hay-on-Wye-Based Brecon Pharmaceuticals Increases Investment in Wales with Expansion

Powys County, Wales (21 February, 2012) Hay-on-Wye based pharmaceutical packaging and clinical trials services specialist Brecon Pharmaceuticals announces the expansion of its storage and distribution capacity, with investment in a state-of-the-art, purpose-built facility in Pontypridd. The investment reflects Brecon Pharmaceuticals’ on-going commitment to continued excellence and to local economic growth.

Founded in 1980 and with premises based in the spectacular Wye Valley, Brecon Pharmaceuticals is one of the leading outsource service providers in the global pharmaceutical industry.

During the past 12 months, the company has defied the economic climate and continued to introduce the latest technologies and market-leading packaging solutions, attracting major contract wins. At the same time, Brecon has maintained its recruitment drive, which has seen an increase in its staff of over 10% in the same period.

Peter Belden, Managing Director comments: “The recent expansion reflects our commitment to innovation and quality through continuous investment in our people, facilities and equipment – a policy that has been rewarded with an almost tenfold increase in sales since 2002.”

Belden continues “The new site in Wales brings new opportunities for the area and the company is committed to recruiting local people from diverse background and providing them with training and expertise that are invaluable to personal development and to the development of the local economy.”

Brecon Pharmaceuticals and its sister company in the United States, Anderson Packaging, supports clients from the earliest stage of R&D through clinical trial and filing and on to commercialisation, packaging and supply. It works with a wide range of clients from small, ‘virtual’ companies through to the biggest global pharmaceutical organisations.

ENDS

Notes to Editor

About Brecon Pharmaceuticals

Founded in 1980, Brecon Pharmaceuticals is acknowledged as one of the leading outsourced-service providers in the global pharmaceutical industry. With unparalleled expertise in clinical trials supplies management and packing of solid dose forms into blisters, strips, wallets, bottles or sachets, backed by full in-house analytical services, Brecon is the preferred partner of the global pharmaceutical community. The company’s purpose-built facilities in Hay-on-Wye, Herefordshire, are the best-equipped and most modern in the UK.

Since 2006 Brecon has been a business of AmerisourceBergen Corporation. AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With $80 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 10,000 people. AmerisourceBergen is ranked #27 on the Fortune 500 list.

Brecon works closely with its AmerisourceBergen sister company Anderson Packaging (Rockford, IL) to deliver harmonised services in Europe, the Americas and beyond.

For further information please visit www.breconpharm.com

For further press information please contact: Michelle Valentine, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA, United Kingdom Tel: + 44 1477 539539 Fax: +44 1477 539 540 E-mail: brecon@scottpr.com